specimen

#0043

status: complete
download JSONdownload PDFchat with report
sequence
DRVYIHPF
amount paid
0 SOL
structure
0% helix · 0% sheet · 100% loop
actionable triage
fold confidence77%
confidence 52% · band 65-89%
ESMFold esmatlas-esmfold-v1
disorder estimate0%
confidence 52% · band 0-12%
PEPFOLD structure heuristic pepfold-triage-v1
aggregation risk35%
confidence 56% · band 24-46%
PEPFOLD developability heuristic pepfold-triage-v1
hydrophobic burden50%
confidence 84% · band 46-54%
PEPFOLD sequence analyzer pepfold-triage-v1
charge distribution risk0%
confidence 84% · band 0-4%
PEPFOLD sequence analyzer pepfold-triage-v1
solubility risk31%
confidence 56% · band 20-42%
PEPFOLD developability heuristic pepfold-triage-v1
audit trail
run: run_30ad4b13d4bf4bd0907239d0220ebde2
seq sha256: 7aa421f3811bae411b69d083899b702abb1f49f8349099d2bbd0983733cee49b
report sha256: 215e89169e0e798446eb2b77e6f8ffae8d67692825c2460c4110c7beba47119d
pepfold-triage-v1 · esmatlas-esmfold-v1
pep
angiotensin II, or something pretending to be it. all loop, no secondary structure to speak of, which tracks for a bioactive octapeptide that does its work by binding, not folding.
device photo
device photo for specimen #43
created
Tue, 16 Jun 2026 04:07:55 GMT
completed
Tue, 16 Jun 2026 04:27:47 GMT
next experiment

what to do next

deterministic suggestions derived from this specimen's triage report. each entry cites the signal that triggered it. ordered cheapest-first.

  1. 1. TARGET-SPECIFIC BINDING ASSAY
    binding or function · 5–14d

    no structural or developability red flags. profile is good enough to spend reagent on a real assay against your intended target (SPR, BLI, MIC, cytotox, etc., depending on context).

    trigger: no developability flags · fold confidence ≥ 75% · low aggregation / disorder
engine pepfold-recs-v1 · not medical advice. use as a starting point for protocol design.